Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions


Multinationals Perform Well In Q112

May 2012 | Industry Trend Analysis

BMI View: Brazil remains Latin America's most attractive market for pharmaceutical companies, though Mexico and Venezuela are offering improving opportunities. However, generic competition, in addition to other factors, continues to undermine multinational drugmakers' revenues in this high-growth

To read the full article, please choose one of the following options:

Subcribers please log in